CMND earnings date and last-quarter result: P/E -0.14. Updated 2026-07-23.
Clearmind Medicine (CMND) Research Hub
Clearmind Medicine (CMND) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 6.12 USD (+4.26%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.14, market cap 0.00B. This hub links to the full technical, earnings and options research available for CMND.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 6.12 USD (+4.26%) |
| 52-week range | 0.706 USD – 7.16 USD |
| Trend regime | Range |
| 14-day RSI | 55.6 (Bullish) |
| Trailing P/E | -0.14 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for CMND
Covered Call on CMND: how it works, illustrative setup around the real 6.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CMND: how it works, illustrative setup around the real 6.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CMND: how it works, illustrative setup around the real 6.12 USD price, max profit/loss, breakeven and when to use it. Educational.
CMND technical analysis: range, last 6.12 USD, RSI 55.6, 52w range 0.706 USD–7.16 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CMND in?
Clearmind Medicine (CMND) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.
Is CMND in an uptrend or downtrend?
As of 2026-10-26, CMND is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CMND's trailing P/E ratio?
CMND's trailing P/E is -0.14, with a market cap of 0.00B. See the earnings research page for full valuation detail.